The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics
Abstract
Increasing resistance to antibiotics worldwide has adverse effects on the effectiveness of standard therapies to eradicate Helicobacter pylori infection. We reviewed guidelines developed by expert groups in Europe, Canada, and the United States for the treatment of H pylori infection. We compared the recommendations of these guidelines, reconciled them, and addressed the increasing resistance of H pylori to antibiotic therapy regimens. The guidelines recommend bismuth quadruple therapy for first-line treatment, replacing clarithromycin-based triple therapy. There is consensus for concomitant 4-drug therapy as an alternative, especially when bismuth is not available. When therapy is unsuccessful, it is likely due to resistance to clarithromycin, levofloxacin, and/or metronidazole; these drugs, if used previously, should be avoided in subsequent eradication attempts. Second-line therapies should be bismuth quadruple therapy or levofloxacin triple therapy, depending on suspected resistance, reserving rifabutin-based triple and high-dose dual amoxicillin proton pump inhibitor therapy for subsequent treatment attempts. The increasing resistance of H pylori to antibiotic therapy necessitates local availability of susceptibility tests for individuals, and establishment of regional and national monitoring programs to develop evidence-based locally relevant eradication strategies. Further studies into the development of more easily accessible methods of resistance testing, such as biomarker analysis of stool samples, are required. Options under investigation include substituting vonoprazan for proton pump inhibitors, adding probiotics, and vaccine development. Narrow-spectrum antibiotics and new therapeutic targets could be identified based on genomic, proteomic, and metabolomic analyses of H pylori.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Self-citationKyoto global consensus report on Helicobacter pylori gastritis
Sugano, K., Tack, J., Kuipers, E. J., Graham, D. Y., El-Omar, E. M., Miura, S., Haruma, K., Asaka, M., Uemura, N., & Malfertheiner, P. (2015) · Gut · doi:10.1136/gutjnl-2015-309252 · Cited by 1,876
Self-citationACG Clinical Guideline: Treatment of Helicobacter pylori Infection
Chey, W. D., Leontiadis, G. I., Howden, C. W., & Moss, S. F. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.563 · Cited by 1,604
Self-citationAccess to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Savoldi, A., Carrara, E., Graham, D. Y., Conti, M., & Tacconelli, E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.007 · Cited by 1,270
Lee, Y.-C., Chiang, T.-H., Chou, C.-K., Tu, Y.-K., Liao, W.-C., Wu, M.-S., & Graham, D. Y. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.028 · Cited by 1,013
Malfertheiner, P., Mégraud, F., OʼMorain, C., Bell, D., Porro, B. G., Deltenre, M., Forman, D., Gasbarrini, G., Jaup, B., Misiewicz, J. J., et al. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199701000-00002 · Cited by 980
Self-citationPlummer, M., Franceschi, S., Vignat, J., Forman, D., & de Martel, C. (2015) · International Journal of Cancer · doi:10.1002/ijc.28999 · Cited by 957
A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain
Lee, A., O'Rourke, J., De Ungria, M., Robertson, B., Daskalopoulos, G., & Dixon, M. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70155-0 · Cited by 937
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
Fallone, C. A., Chiba, N., van Zanten, S. V., Fischbach, L., Gisbert, J. P., Hunt, R. H., Jones, N. L., Render, C., Leontiadis, G. I., Moayyedi, P., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.006 · Cited by 927
Self-citationMegraud, F., Coenen, S., Versporten, A., Kist, M., Lopez-Brea, M., Hirschl, A. M., Andersen, L. P., Goossens, H., Glupczynski, Y., & on behalf of the Study Group participants (2013) · Gut · doi:10.1136/gutjnl-2012-302254 · Cited by 839
Review article: the global emergence of Helicobacter pylori antibiotic resistance
Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., & Valasek, M. A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13497 · Cited by 743
ACG and CAG Clinical Guideline: Management of Dyspepsia
Moayyedi, P. M., Lacy, B. E., Andrews, C. N., Enns, R. A., Howden, C. W., & Vakil, N. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.154 · Cited by 689
Malfertheiner, P., Bazzoli, F., Delchier, J.-C., Celiñski, K., Giguère, M., Rivière, M., & Mégraud, F. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60020-2 · Cited by 523
Self-citationKuo, Y.-T., Liou, J.-M., El-Omar, E. M., Wu, J.-Y., Leow, A. H. R., Goh, K. L., Das, R., Lu, H., Lin, J.-T., Tu, Y.-K., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30219-4 · Cited by 319
Zeng, M., Mao, X.-H., Li, J.-X., Tong, W.-D., Wang, B., Zhang, Y.-J., Guo, G., Zhao, Z.-J., Li, L., Wu, D.-L., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60310-5 · Cited by 305
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States
El-Serag, H. B., Kao, J. Y., Kanwal, F., Gilger, M., LoVecchio, F., Moss, S. F., Crowe, S., Elfant, A., Haas, T., Hapke, R. J., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.03.013 · Cited by 260
Self-citationKagami, T., Sahara, S., Ichikawa, H., Uotani, T., Yamade, M., Sugimoto, M., Hamaya, Y., Iwaizumi, M., Osawa, S., Sugimoto, K., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13588 · Cited by 252
Duck, W. M., Sobel, J., Pruckler, J. M., Song, Q., Swerdlow, D. L., Friedman, C. R., Sulka, A. C., Swaminathan, B., Taylor, T., Hoekstra, M., et al. (2004) · Emerging infectious diseases · doi:10.3201/eid1006.030744 · Cited by 221
Yang, J.-C., Lin, C.-J., Wang, H.-L., Chen, J.-D., Kao, J. Y., Shun, C.-T., Lu, C.-W., Lin, B.-R., Shieh, M.-J., Chang, M.-C., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.036 · Cited by 202
Jung, Y. S., Kim, E. H., & Park, C. H. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14130 · Cited by 183
Ford, A. C., Delaney, B. C., Forman, D., & Moayyedi, P. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40014.x · Cited by 177
McFarland, L. V., Huang, Y., Wang, L., & Malfertheiner, P. (2015) · United European Gastroenterology Journal · doi:10.1177/2050640615617358 · Cited by 177
Self-citationHelicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models
Burkitt, M. D., Duckworth, C. A., Williams, J. M., & Pritchard, D. M. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027649 · Cited by 167
Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans
Shiota, S., Reddy, R., Alsarraj, A., El‐Serag, H. B., & Graham, D. Y. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.02.005 · Cited by 163
Sugimoto, M., Furuta, T., Shirai, N., Kodaira, C., Nishino, M., Ikuma, M., Ishizaki, T., & Hishida, A. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00508.x · Cited by 150
Helicobacter pyloritherapy: a paradigm shift
Graham, D. Y., & Dore, M. P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1178065 · Cited by 141
Li, M., Oshima, T., Horikawa, T., Tozawa, K., Tomita, T., Fukui, H., Watari, J., & Miwa, H. (2018) · Helicobacter · doi:10.1111/hel.12495 · Cited by 139
CanadianHelicobacter pyloriConsensus Conference
Hunt, R. H., & Thomson, A. B. (1998) · Canadian Journal of Gastroenterology · doi:10.1155/1998/170180 · Cited by 138
Role of Bismuth in the Eradication of Helicobacter pylori
Alkım, H., Köksal, A. R., Boğa, S., Şen, İ., & ALKIM, C. (2016) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000389 · Cited by 126
Malfertheiner, P., Selgrad, M., Wex, T., Romi, B., Borgogni, E., Spensieri, F., Zedda, L., Ruggiero, P., Pancotto, L., Censini, S., et al. (2018) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30125-0 · Cited by 107
Self-citationMacy, E. M. (2015) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000173 · Cited by 73
Potent Acid Suppression with PPIs and P-CABs: What’s New?
Hunt, R. H., & Scarpignato, C. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0206-y · Cited by 72
Kelly, C. R., Kim, A. M., Laine, L., & Wu, G. D. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.028 · Cited by 70
Yang, X., Koohi‐Moghadam, M., Wang, R., Chang, Y., Woo, P. C. Y., Wang, J., Li, H., & Sun, H. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2003887 · Cited by 54
Gatta, L., Scarpignato, C., Fiorini, G., Belsey, J., Saracino, I. M., Ricci, C., & Vaira, D. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14597 · Cited by 54
Diagnosis of Helicobacter pylori infection
Skrebinska, S., Mégraud, F., & Bessède, E. (2018) · Helicobacter · doi:10.1111/hel.12515 · Cited by 46
Song, H., Zhou, L., Liu, D., Yao, X., & Li, Y. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/9379480 · Cited by 43
Pasala, C., Chilamakuri, C. S. R., Katari, S. K., Nalamolu, R. M., Bitla, A. R. R., & Umamaheswari, A. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.05.037 · Cited by 31
The Effects of Nocturnal Acid Breakthrough on Helicobacter pylori Eradication
Kim, J. I., Park, S., Kim, J. K., Chung, I. S., Chung, K. W., & Sun, H. S. (2002) · Helicobacter · doi:10.1046/j.1523-5378.2002.00105.x · Cited by 29
Antibiotic Resistance Is the Key Element in Treatment of Helicobacter pylori Infection
Mégraud, F. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.012 · Cited by 28
Zhang, S., Moise, L., & Moss, S. F. (2011) · Human Vaccines · doi:10.4161/hv.7.11.17655 · Cited by 21
Self-citationCurrent Status and Prospects for a Helicobacter pylori Vaccine
Blanchard, T. G., & Czinn, S. J. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.05.013 · Cited by 17
Singh, G., & Singh, V. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1302361 · Cited by 12
Furuta, T., Sahara, S., Ichikawa, H., Kagami, T., Uotani, T., Yamade, M., Sugimoto, M., Hamaya, Y., Iwaizumi, M., Osawa, S., et al. (2016) · Gastroenterology · doi:10.1016/s0016-5085(16)32958-4 · Cited by 7
Cited by
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Self-citationMalfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R., Schulz, C., Smith, S. I., & Suerbaum, S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00431-8 · Cited by 1,191
Self-citationHelicobacter pylori infection and antibiotic resistance — from biology to clinical implications
Tshibangu-Kabamba, E., & Yamaoka, Y. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00449-x · Cited by 517
Kumar, S., Metz, D. C., Ellenberg, S., Kaplan, D. E., & Goldberg, D. S. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.10.019 · Cited by 286
Zhou, S., Yu, Y., Tian, J., Wang, X., Zeng, M., & Song, H. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1704508 · Cited by 2
“Against this background, guidelines recommend bismuth-containing or bismuth-free quadruple therapy as the preferred empirical treatment regimen (Fallone et al., 2019).”
Metadata
- Authors
- Fallone, C. A., Moss, S. F., & Malfertheiner, P.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 157
- Issue
- 1
- Pages
- 44-53
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2935703421
- Cited by
- 286
- References
- 47
- FWCI
- 35.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.